Use of cuprous thiocyanate as a short-term continuous marker for faeces.
作者信息
Dick M
出版信息
Gut. 1969 May;10(5):408-12. doi: 10.1136/gut.10.5.408.
Abstract
摘要
相似文献
1
Use of cuprous thiocyanate as a short-term continuous marker for faeces.
Gut. 1969 May;10(5):408-12. doi: 10.1136/gut.10.5.408.
2
Estimation of faecal fat excretion using cuprous thiocyanate as a continuous marker.
Gut. 1969 Sep;10(9):754-9. doi: 10.1136/gut.10.9.754.
3
A method for estimating faecal fat excretion using cuprous thiocyanate as a marker.
Br J Surg. 1969 May;56(5):380.
4
Quantitative analysis of single stool samples using a continuous marker.
Am J Dig Dis. 1972 Aug;17(8):761-5. doi: 10.1007/BF02231650.
5
[Spectrophotometric determination of copper in serum, urine and faeces].
Clin Chim Acta. 1972 Apr;38(1):119-26. doi: 10.1016/0009-8981(72)90216-1.
6
Use of barium sulphate as a continuous marker for faeces.
J Clin Pathol. 1967 Mar;20(2):216-8. doi: 10.1136/jcp.20.2.216.
7
[A method for the determination of thiocyanate in serum].
Z Med Lab Diagn. 1982;23(4):226-8.
8
A colourimetric procedure for the determination of thiocyanate in plasma.
J Anal Toxicol. 1982 Jan-Feb;6(1):53-5. doi: 10.1093/jat/6.1.53.
9
Determination of thiocyanate in human serum by ion chromatography.
Analyst. 1988 Mar;113(3):389-92. doi: 10.1039/an9881300389.
10
Standardisation of methods for the estimation of thiocyanate and iodine in foodstuff.
Indian J Physiol Pharmacol. 1986 Jul-Sep;30(3):241-7.
引用本文的文献
1
Polyethylene glycol 4000 as a continuously administered non-absorbable faecal marker for metabolic balance studies in human subjects.
Gut. 1971 Aug;12(8):654-60. doi: 10.1136/gut.12.8.654.
2
Assessment of fat malabsorption.
J Clin Pathol. 1983 Dec;36(12):1362-6. doi: 10.1136/jcp.36.12.1362.
3
Estimation of faecal fat excretion using cuprous thiocyanate as a continuous marker.
Gut. 1969 Sep;10(9):754-9. doi: 10.1136/gut.10.9.754.
4
Quantitative analysis of single stool samples using a continuous marker.
Am J Dig Dis. 1972 Aug;17(8):761-5. doi: 10.1007/BF02231650.
5
Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs.
Br Med J. 1972 Oct 7;4(5831):9-12. doi: 10.1136/bmj.4.5831.9.
6
The 14C-glycocholate test in diabetic diarrhoea.
Br Med J. 1976 Sep 18;2(6037):673-5. doi: 10.1136/bmj.2.6037.673.
7
Comparison of radio-opaque pellets and chromium sesquioxide as inert markers in studies requiring accurate faecal collections.
Gut. 1978 May;19(5):371-6. doi: 10.1136/gut.19.5.371.
8
Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
Br Med J. 1978 May 27;1(6124):1382-6. doi: 10.1136/bmj.1.6124.1382.
9
Radio-opaque pellets as faecal markers for faecal fat estimation in malabsorption.
Gut. 1979 Jul;20(7):581-4. doi: 10.1136/gut.20.7.581.
10
Appraisal of the 14C-glycocholate acid test with special reference to the measurement of faecal 14C excretion.
Gut. 1977 Sep;18(9):742-8. doi: 10.1136/gut.18.9.742.
本文引用的文献
1
The determination of thiocyanate in blood serum.
Biochem J. 1944;38(5):385-8. doi: 10.1042/bj0380385.
2
EXPERIENCES WITH THE USE OF INTERRUPTED CARMINE RED AND CONTINUOUS CHROMIUM SESQUIOXIDE MARKING OF HUMAN FAECES WITH REFERENCE TO CALCIUM, PHOSPHORUS, AND MAGNESIUM.
Gut. 1964 Jun;5(3):274-9. doi: 10.1136/gut.5.3.274.
3
Experience with the chromic oxide method of fecal marking in metabolic balance investigations on humans.
J Clin Invest. 1960 Jun;39(6):854-63. doi: 10.1172/JCI104106.
4
An improved colorimetric enzymatic assay of ceruloplasmin.
J Lab Clin Med. 1961 Jul;58:161-8.
5
Use of barium sulphate as a continuous marker for faeces.
J Clin Pathol. 1967 Mar;20(2):216-8. doi: 10.1136/jcp.20.2.216.
Zotero 插件